Épron Quievy & Associé advised Paltech SAS within it’s second fundraising
After a first fundraising in 2021, Paltech SAS closed in October 2023 a new round of more than one million euros fully subscribed by private investors.
Founded by doctors Réginald Allouche and Charles-Henri Malbert in 2021, Paltech SAS is an innovative company dedicated to the research for a curative treatment for type 2 diabetes.
Type 2 diabetes is a developing disease that affects more than 800 million people worldwide. The complications induced by this disease both in medium and long terms are strongly disabling. Type 2 diabetes is notably the main cause in non-traumatic amputations, blindness, kidney failure and neuropathy. Most treatments currently available are palliative and allow individuals to live with the disease without curing it. Paltech is developing a medical device that under certain conditions might cure people with type 2 diabetes. The first experiments made it possible to validate the proof of concept. Clinical trials with human beings are planned to start in 2025.
Paltech SAS is assisted by Épron Quievy & Associés on a day-to-day basis with Étienne Épron, partner and Cassandra Gimbert, associate.
More info on Paltech http://www.paltech.fr
Latest news
September 5, 2024
Epron Quievy & Associés advised Proclus SAS within a new capital increase
In August 2024, Etienne Epron, partner and Margot De Almeida Lopes, associate, were delighted to assist Proclus SAS on the occasion of a new increase of its share capital. Founded in 2022, Proclus SAS is a young leading independent French player in the field of the re-use of professional electrical equipment. The company’s activities are… Continue reading Epron Quievy & Associés advised Proclus SAS within a new capital increase
August 20, 2024
EQA is hiring a junior associate to join the team
Our firm is currently seeking to hire a junior / mid-level associate with relevant work experience in corporate law, mergers and acquisitions, and tax. Ideally, the candidate will show between 1 and 3 years of work experience and demonstrate a side but strong interest in litigation, particularly in proceedings before the courts of the European… Continue reading EQA is hiring a junior associate to join the team
May 24, 2024
Unfreezing assets held with EUROCLEAR
After months of struggle with Belgian authorities, EQA is happy to share that on May 24, 2024, we have obtained the authorizations necessary for the release of funds and securities held on behalf of our client by NSD and alfa-Bank within EUROCLEAR, for a cumulated value of more than a million euro.
May 2, 2024
“Compensation, an operation to dissect”
Jean-François Quievy, managing partner of the firm, has published a new article on the various aspects of the compensation mechanism in contract law, disseminated on actu-juridique.fr and soon to be published in the Petites Affiches. The full article is accessible by following this link: “Compensation, an operation to dissect”